Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress Seite 1

25.05.2023 - Incyte (Nasdaq:INCY) today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology (ASCO) Annual Meeting held June 2-6 in Chicago, and at the ... Seite 1

Related Keywords

,Activin Receptor Like Kinase ,Hematologic Malignancies ,Myelodysplastic Syndromes ,Open Label Study ,Add On Therapy ,Suboptimal Response ,Incyte ,